Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
gene editing
2
×
gilead sciences
hiv
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
2
×
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alector
alkermes
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
avrobio
What
bio
roundup
acquisitions
biggest
biopharma
build
buy
ceo
company’s
congress
congressional
crispr
daniel
debut
drug
dyne’s
executives
feud
gilead
group
isn’t
known
later
microbiome
month
moves
new
ny
openly
o’day
pharma
pipeline
roster
sciences
scores
seagen
spectacles
splash
spoken
stay
Language
unset
Current search:
hiv
×
photo
×
" texas blog main "
×
" gene editing "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More